Following injury to the central nervous system (CNS), severed axons fail to regenerate and re-form functional connections. Accordingly, CNS neurons appear to lack the intrinsic ability to modify their gene expression patterns to activate a robust regenerative response, perhaps as a result of limited plasticity in the adult brain (Davis, 2013). On the other hand, neurons of the peripheral nervous system (PNS) have been shown to modulate gene expression in response to injury, promoting axon regrowth that results in restoration of function. Transcriptomic analyses of differential gene expression between PNS and CNS neurons following injury suggest the involvement of numerous genes in successful PNS regeneration (Smith et al., 2011; Chandran et al., 2016). These studies provide insight into the identities of transcription factors (TFs) that, by controlling large suites of regeneration associated genes, could aid in promoting CNS regeneration.
Previous research by the Lemmon-Bixby group using microarrays, subtractive hybridization and RNA-seq found the TF “signal transducer and activator of transcription 3” (Stat3) to be enriched and likely activated in dorsal root ganglion (DRG) neurons compared to CNS neurons (Smith et al., 2011). Stat3 had previously been implicated, via phosphorylation and translocation to the nucleus, in the successful regeneration of the peripheral branch of DRG neurons following injury. Furthermore, blocking Stat3 impeded the regeneration of the DRG central branch that follows a conditioning lesion to the peripheral branch (Tedeschi, 2011). Overexpression of a constitutively active form of Stat3 promoted regeneration in the optic nerve (Pernet et al., 2013). These findings suggested that overexpression of Stat3 in the CNS could play a role in promoting axon growth and regeneration.
Various studies have found that altering gene expression – via overexpression or knockdown – in the CNS can lead to regeneration. While overexpression of genes such as CREB, Klf7, Jun, and Sox11, and knockdown of PTEN, SOCS3, and Klf4, have led to promising regeneration, functional recovery remains elusive. VP16 is a viral activation domain responsible for activation of immediate early genes in herpes simplex virus. It functions by recruiting co-factors, histone acetyltransferases, and chromatin remodeling proteins, allowing TFs to initiate transcription more effectively (Hirai et al., 2010). In the cases of Klf7 and CREB, fusion of VP16 to these TFs helped promote growth and regeneration following TF overexpression (Gao et al., 2004; Blackmore et al., 2012). This indicated that increasing TF activity with methods such as VP16 fusion can promote increased regeneration, motivating our Stat3 experiments. Our studies focused on constitutive activation of Stat3 via mutation, as well as fusion of constitutively activated (CA) Stat3 with the VP16 transactivation domain, in order to promote CNS axon regeneration. Our major finding was that overexpression of “hyperactivated” Stat3 – VP16-Stat3CA – substantially promoted neurite outgrowth in cortical neurons in vitro as well as axon regeneration in retinal ganglion cells in vivo, and did both to a greater extent that Stat3CA alone (Mehta et al., 2016).
In addition to fusing wild type Stat3 (Stat3WT) to a VP16 activation domain, we tested this activation domain in the context of Stat3CA. In order for Stat3 to become active and translocate to the nucleus, it must be phosphorylated and homodimerize. The Stat3CA variant, however, has two cysteines introduced into Stat3's SH2 binding domain, allowing Stat3CA to homodimerize constitutively, bypassing phosphorylation by upstream activators such as CNTF/Janus kinases. Thus, Stat3CA fused to VP16 would be “hyperactivated”, translocating to the nucleus without upstream activation, and able to regulate downstream genes more effectively by chromatin modification. Following this logic, the hyperactivated form of Stat3 – VP16-Stat3CA – should not only promote neurite outgrowth and axon regeneration (see above), but also strongly increase expression levels of regeneration-associated genes. Indeed, qPCR analysis following VP16-Stat3CA overexpression showed an increase in Stat3-associated transcriptional activity, as indicated by an increase in expression of the downstream regeneration-associated genes ATF3 and Sprr1a (as well as Stat3 itself), compared to an inactive (mCherry) control and to overexpression of Stat3CA without VP16 fusion (Mehta et al., 2016).
To test whether overexpression of VP16-Stat3CA could promote CNS axon regeneration in vivo, we used the optic nerve crush model, which has been widely used to study regeneration in vivo, and has led to the identification of PTEN knockdown and CNTF treatment as robust promoters of axon regeneration. Since a previous study indicated that overexpression of Stat3CA leads to optic nerve regeneration following a crush injury (Pernet et al., 2013), our experiment compared regeneration following treatment with GFP (control), Stat3CA, and VP16-Stat3CA. We confirmed that overexpression of Stat3CA led to significant regeneration (with axons growing up to 200 μm), but found that overexpression of VP16-Stat3CA promoted axon regeneration up to 1 mm past the injury site at 2 weeks following the crush (Mehta et al., 2016).
Our results, along with those of other studies, indicate that manipulation of Stat3 has strong effects on axon regeneration in the CNS. An analysis of Stat3 downstream genes followed by gene ontology (GO) term analysis suggests an explanation for the ability of Stat3 overexpression to promote CNS regeneration ([Figure 1], Supplementary Table 1 [SUPPORTING:1]). Stat3 regulates pathways of neurogenesis, nervous system development, and the wound healing response in addition to other relevant pathways. Moreover, our qPCR results indicate that hypractivated Stat3 (VP16-Stat3CA) increased expression of the regeneration-associated genes ATF3 and Sprr1a more strongly than Stat3CA alone (Mehta et al., 2016). These findings suggest that overexpression of hyperactivated Stat3 activates regeneration-relevant pathways more effectively than Stat3CA without the VP16 addition.{Figure 1}
While we showed successful CNS regeneration in vivo with VP16-Stat3CA overexpression, other transcription factors, such as Klf7, CREB, and cJun, are also likely to play major roles in this process (Gao et al., 2004; Blackmore et al., 2012; Lerch et al., 2014). Our studies showed that it was crucial to use VP16 as well as a constitutively active Stat3 to promote robust axon regeneration. Thus it is worth considering that simple overexpression of a TF may not lead to successful regeneration. Furthermore, another study showed that while overexpression of the TF Sox11 did promote axon regeneration of the corticospinal tract after a pyramidotomy, it led to worse behavioral recovery compared to animals without Sox11 overexpression (Wang et al., 2015). A combinatorial approach to TF overexpression showed that while a combination of Stat3, Smad1, Jun, and ATF3 promoted axon regeneration of the central branch of DRG neurons, it was not more effective than overexpression of Jun alone (Fagoe et al., 2015). Interestingly, we previously showed that overexpression of certain combinations of 2 transcription factors can increase neurite outgrowth in vitro compared to overexpression of a single transcription factor (Lerch et al., 2014). Thus, it is possible that the right combination of hyperactivated transcription factors could lead to more substantial CNS axon regeneration as well as functional recovery. Taken together, these studies show that, when it comes to axon regeneration, one must consider the activation state of the TF(s), their ability to work together, and the ultimate effects on behavior.
This work was supported by NIH HD057632 to VPL and JLB. VPL holds the Walter G. Ross Distinguished Chair in Developmental Neuroscience.[12]
Open peer reviewer: Barbara Haenzi.
Additional file: Open peer review report 1.[SUPPORTING:2]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2017. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
[...]CNS neurons appear to lack the intrinsic ability to modify their gene expression patterns to activate a robust regenerative response, perhaps as a result of limited plasticity in the adult brain (Davis, 2013). To test whether overexpression of VP16-Stat3CA could promote CNS axon regeneration in vivo, we used the optic nerve crush model, which has been widely used to study regeneration in vivo, and has led to the identification of PTEN knockdown and CNTF treatment as robust promoters of axon regeneration. Since a previous study indicated that overexpression of Stat3CA leads to optic nerve regeneration following a crush injury (Pernet et al., 2013), our experiment compared regeneration following treatment with GFP (control), Stat3CA, and VP16-Stat3CA. Interestingly, we previously showed that overexpression of certain combinations of 2 transcription factors can increase neurite outgrowth in vitro compared to overexpression of a single transcription factor (Lerch et al., 2014). [...]it is possible that the right combination of hyperactivated transcription factors could lead to more substantial CNS axon regeneration as well as functional recovery.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL
2 Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL; Center for Computational Science, University of Miami Miller School of Medicine, Miami, FL; Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL; Molecular & Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL
3 Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL; Center for Computational Science, University of Miami Miller School of Medicine, Miami, FL; Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL